Thank you to member Kaye for this very interesting information.
Subject: Fw: Cellerant $13.5M Contract Will Fund Lead Program
Barbara,
I ran across this article on Irving Weissman. Looks like he still has money riding on the approval of his adult stem cell therapy that the military is interested in.
Probably not just for military use. Found this quote from google search of CLT-008. Universal therapy with widespread application.
"CLT-008 is the result of nearly 50 years of research into the adult blood forming system. This research began with the first bone marrow transplants, and culminated in the characterization and isolation of the human blood forming stem cell and its downstream progeny. CLT-008 will be the first adult-stem cell derived product with the potential to become a universal therapy with widespread application. Cellerant intends to develop the drug for the treatment of severely ill patients, as well as a countermeasure to nuclear terror."
http://www.tmcnet.com/usubmit/2008/09/23/3666920.htm You may need to click on this twice to bring it up
Subject: Fw: Cellerant $13.5M Contract Will Fund Lead Program
Barbara,
I ran across this article on Irving Weissman. Looks like he still has money riding on the approval of his adult stem cell therapy that the military is interested in.
Probably not just for military use. Found this quote from google search of CLT-008. Universal therapy with widespread application.
"CLT-008 is the result of nearly 50 years of research into the adult blood forming system. This research began with the first bone marrow transplants, and culminated in the characterization and isolation of the human blood forming stem cell and its downstream progeny. CLT-008 will be the first adult-stem cell derived product with the potential to become a universal therapy with widespread application. Cellerant intends to develop the drug for the treatment of severely ill patients, as well as a countermeasure to nuclear terror."
http://www.tmcnet.com/usubmit/2008/09/23/3666920.htm You may need to click on this twice to bring it up